ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,231Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 288

$539K Total Retail Price of All Prescriptions

Rank: 62 out of 288

635 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 635 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 635 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 655 607 1 1
FUROSEMIDE 467 449 2 5
LISINOPRIL 438 404 3 4
OMEPRAZOLE 369 326 4 3
LEVOTHYROXINE SODIUM 360 353 5 2
HYDROCHLOROTHIAZIDE 349 337 6 13
HYDROCODONE-ACETAMINOPHEN 299 272 S3 7 7
AMLODIPINE BESYLATE 266 252 8 6
BENAZEPRIL HCL 262 249 9 52
METOPROLOL TARTRATE 225 218 10 8
ATORVASTATIN CALCIUM 213 201 11 14
CARVEDILOL 206 203 12 27
METFORMIN HCL 202 193 13 12
CITALOPRAM HBR 197 176 14 18
ATENOLOL 184 178 15 10
METOPROLOL SUCCINATE 171 154 16 15
LOSARTAN POTASSIUM 171 164 16 16
GABAPENTIN 162 145 18 17
SPIRONOLACTONE 161 156 19 36
POTASSIUM CHLORIDE 154 146 20 11
TRIAMTERENE-HCTZ 150 150 21 28
FAMOTIDINE 136 124 22 68
WARFARIN SODIUM 131 127 23 9
CLOPIDOGREL 117 110 24 47
SERTRALINE HCL 104 94 25 25
TRAMADOL HCL 96 84 26 19
LEVEMIR FLEXPEN 96 96 26 187
CRESTOR 92 92 28 26
ALLOPURINOL 91 81 29 23
RANITIDINE HCL 90 73 30 33
PLAVIX 86 76 31 71
TAMSULOSIN HCL 84 68 32 24
POLYETHYLENE GLYCOL 3350 83 70 33 38
DONEPEZIL HCL 82 82 34 29
ALENDRONATE SODIUM 78 78 35 20
LOVASTATIN 78 78 35 46
DIOVAN 76 73 37 53
GLIMEPIRIDE 75 70 38 32
LANTUS 70 70 39 31
ENALAPRIL MALEATE 67 63 40 40
AZITHROMYCIN 66 63 41 49
PAROXETINE HCL 62 62 42 54
NAMENDA 58 58 43 39
PRAVASTATIN SODIUM 52 51 44 21
FLUOXETINE HCL 51 51 45 64
DIGOXIN 51 39 45 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.